T1	Organism 108 129	Plasmodium falciparum
T2	OrganismPart 81 95	Red Blood Cell
T3	Strain 45965 45968	3D7
T4	CellType 46080 46088	schizont
T5	Staining 46726 46732	Giemsa
T6	AcquisitionMethod 47166 47176	label-free
T7	Treatment 47279 47281	IC
T8	Treatment 47284 47286	EC
T9	Treatment 47293 47298	EC-BA
T10	AcquisitionMethod 47331 47339	labeling
T11	CleavageAgent 47425 47432	trypsin
T12	Label 48036 48051	Tandem mass tag
T13	Label 48053 48056	TMT
*	Equiv T12 T13
T14	FractionationMethod 48091 48136	hydrophilic interaction liquid chromatography
T15	FractionationMethod 48138 48143	HILIC
*	Equiv T14 T15
T16	NumberOfFractions 48466 48474	12 to 15
T17	Modification 50740 50773	carbamidomethylation of cysteines
A1	Modification T17 fixed
T18	Modification 50807 50831	oxidation of methionine,
A2	Modification T18 variable
T19	Modification 50832 50862	protein N-terminal acetylation
A3	Modification T19 variable
T20	Modification 50868 50915	serine/threonine/tyrosine (STY) phosphorylation
A4	Modification T20 variable
T21	PrecursorMassTolerance 51000 51006	20 ppm
T22	FragmentMassTolerance 51011 51017	0.5 Da
T23	PrecursorMassTolerance 51693 51698	5 ppm
T24	FragmentMassTolerance 51703 51709	0.5 Da
T25	NumberOfFractions 47911 47919	12 to 15
T26	FractionationMethod 47807 47850	strong cation exchange (SCX) chromatography
T27	NumberOfBiologicalReplicates 14879 14882	two
